Research graph
References from Navigating challenges in implementing watch-and-wait strategies for rectal cancer: From clinical trials to real-world practice. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Global colorectal cancer burden in 2020 and projections to 2040
10.1016/j.tranon.2021.101174 · 2021 · External reference
Preoperative versus postoperative chemoradiotherapy for rectal cancer
10.1056/nejmoa040694 · 2004 · External reference
Unresolved reference
External reference
Distinct Prognosis of High Versus Mid/Low Rectal Cancer: a Propensity Score-Matched Cohort Study
10.1007/s11605-018-04072-1 · 2019 · External reference
Preoperative Treatment of Locally Advanced Rectal Cancer
10.1056/nejmoa2303269 · 2023 · External reference
Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: it may take longer than you think!
10.1097/dcr.0000000000001338 · 2019 · External reference
Management of early rectal cancer
10.1002/bjs.6127 · 2008 · External reference
Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015
10.1097/coc.0000000000000674 · 2020 · External reference
Multidisciplinary management of locally advanced rectal cancer: neoadjuvant approaches
10.6004/jnccn.2013.0071 · 2013 · External reference
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
10.1001/jamaoncol.2018.0071 · 2018 · External reference
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
10.1016/s1470-2045(21)00079-6 · 2021 · External reference
Unresolved reference
External reference
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
10.1016/s1470-2045(20)30555-6 · 2021 · External reference
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
10.1200/jco.19.00308 · 2019 · External reference
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
10.1200/jco.22.00032 · 2022 · External reference
An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal Cancer
10.1097/dcr.0000000000003209 · 2024 · External reference
Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization
10.1007/dcr.0b013e3181f42b89 · 2010 · External reference
Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial
10.1097/dcr.0000000000003096 · 2024 · External reference
What predicts complete response to total neoadjuvant therapy in locally advanced rectal cancer
10.1097/dcr.0000000000003395 · 2025 · External reference
MRI after treatment of locally advanced rectal cancer: how to report tumor response–the MERCURY experience
10.2214/ajr.11.8210 · 2012 · External reference
Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience
10.1200/jco.2011.34.9068 · 2011 · External reference
Watch-and-Wait Approach to Rectal Cancer: The Role of Imaging
10.1148/radiol.221529 · 2023 · External reference
Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer
10.1016/j.ejso.2023.01.026 · 2023 · External reference
What to do with suspected nodal regrowth on MRI during follow-up in an organ preservation approach for rectal cancer
10.1097/dcr.0000000000003385 · 2024 · External reference
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results
10.1097/01.sla.0000141194.27992.32 · 2004 · External reference
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
10.1016/s1470-2045(15)00215-6 · 2015 · External reference
Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis
10.1097/sla.0000000000002761 · 2018 · External reference
Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group
10.1097/dcr.0000000000003586 · 2025 · External reference
WW vs TME in patients with rectal cancer with a complete or near-complete response to TNT: Pooled analysis of CAO/ARO/AIO-12 and OPRA trials
10.1200/jco.2025.43.4_suppl.21 · 2025 · External reference
NCCN guidelines insights: rectal cancer, version 6.2020: featured updates to the NCCN guidelines
10.6004/jnccn.2020.0032 · 2020 · External reference
Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): A long-term prospective, multicentre, cohort study
2020 · External reference
Defining low anterior resection syndrome: a systematic review of the literature
10.1111/codi.13767 · 2017 · External reference
Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study
10.1097/dcr.0000000000000862 · 2017 · External reference
Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer
10.1200/jco.2024.42.17_suppl.lba3512 · 2024 · External reference
“Watch and wait” strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons
2019 · External reference
Unresolved reference
External reference
Detection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study
10.1016/s2468-1253(19)30413-3 · 2020 · External reference
Clinical consequences of diagnostic variability in the histopathological evaluation of early rectal cancer
10.1016/j.ejso.2023.02.008 · 2023 · External reference
Artificial intelligence recognition of pathological T stage and tumor invasion in rectal cancer based on large panoramic pathological sections
10.1016/j.imed.2022.03.004 · 2022 · External reference
Concordance of MRI With Pathology for Primary Staging of Rectal Cancer in Routine Clinical Practice: A Single Institution Experience
10.1067/j.cpradiol.2023.08.016 · 2024 · External reference
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis
10.1186/s12885-021-08773-w · 2021 · External reference
Predicting the prognosis of lower rectal cancer using preoperative magnetic resonance imaging with artificial intelligence
10.1007/s10151-023-02766-6 · 2023 · External reference
Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis
10.1007/s11547-024-01796-w · 2024 · External reference
Machine learning model for prediction of permanent stoma after anterior resection of rectal cancer: A multicenter study
10.1016/j.ejso.2024.108386 · 2024 · External reference
Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial
10.1097/sla.0b013e3182196e1f · 2011 · External reference
